Neumora Therapeutics, Inc. (NMRA) Tops Q3 EPS by 20c

Neumora Therapeutics, Inc. (NASDAQ: NMRA) reported Q3 EPS of ($0.45), $0.20 better than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Neumora Therapeutics, Inc. (NMRA) click here.

You May Also Be Interested In

• Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
• Edison International (EIX) PT Lowered to $63 at UBS
• Nasdaq grants Snail Games conditional listing extension for SNAL stock